Advocacy intelligence hub — real-time data for patient organizations
VARIZIG: FDA approved
Post exposure prophylaxis of varicella in high risk individuals to reduce the severity of varicella
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
VARIZIG
Cangene bioPharma, Inc.